866-503-0857

Medicare pharmacy (injectable drugs): 1-866-503-0857 ${tty} Non-Medicare plans (includes individual & family plans): 1-888-632-3862 ${tty}, (choose precertification prompt) Non …

Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.503 Sunport Lane, Orlando, FL 32809. Medication Precertification Request. Phone: 1-866-503-0857. Page 1 of 2 FAX: 1-888-267-3277. (All fields must be completed and legible for Precertification Review) For Medicare Advantage Part B: Please indicate: Start of treatment: Start date / / FAX: 1-844-268-7263 Continuation of therapy: Date of last ...503 Sunport Lane, Orlando, FL 32809. Phone: 1-866-503-0857 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax:Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date . Continuation of therapy, Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT ...503 Sunport Lane, Orlando, FL 32809. Phone: 1-866-503-0857 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax:Handy tips for filling out 866 503 0857 online. Printing and scanning is no longer the best way to manage documents. Go digital and save time with airSlate SignNow, the best solution for electronic signatures.Use its powerful functionality with a simple-to-use intuitive interface to fill out 866 752 7021 online, eSign them, and quickly share them without jumping tabs.PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product Page 1 of 3 is Eligard. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / /Policy: Under some plans, including plans that use an open or closed formulary, Yervoy is subject to precertification. If precertification requirements apply Aetna considers Yervoy to be medically necessary for those members who meet the following precertification criteria:

1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment.Repository (H.P. Gel) Aetna Precertification Notification 503 Sunport Lane Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 Medication Precertification Request (All fields must be completed. How It Works. Open form follow the instructions. Easily sign the form with your fingerPage 1 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263. Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / /.Specialty Pharmacy Clinical Policy Bulletins. Aetna Non-Medicare Prescription Drug Plan. Subject: Remicade. Drug. Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service ...1-866-503-0857 . or fax applicable request forms to . 1-888-267-3277, with the following exceptions: • For precertification of pharmacy-covered specialtydrugs (noted with*) when memberis enrolled in a commercial plan, call . 1-855-240-0535 . or fax applicable request forms to . 1-877-269-9916 • Providers can use the drug-specificPHONE: 1-866-503-0857 For other lines of business: Please use other form. Note: Neupogen is non preferred. Zarxio is preferred. Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.If it is medically necessary for a member to be treated initially with a medication subject to step-therapy, the member, a person appointed to manage the member's care, or the member's treating physician may contact the Aetna Pharmacy Management Precertification Unit to request coverage as a medical exception at 1-866-503-0857 (See Medical ...Erythropoietin Injectable Medication Precertification Request Aranesp®/Epogen®/Procrit®. Aetna Precertification Notification 503 Sunport Lane Orlando, FL 32809 Phone: 1-866 …

Precertification for these drug classes may be obtained by calling 1-866-503-0857. A "Precertification Request for Injectable Medication and/or Outpatient Infusion Services" form can be located on Aetna's secure provider website, by selecting "Aetna Support Center", then "Forms Library". The form can be faxed to 1-888-267-3277. ...The best way to double-check that a number is a scammer is to type the number into your favorite search engine. This method is useful if your scam blocker catches a number, you accidentally hang ...Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date . Continuation of therapy, Date of last treatment .Phone: 1-866-752-7021 FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: Continuation of therapy, date of last treatment: Precertification Requested By: Phone: Fax:1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (continued)Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Intravenous Immunoglobulins (IVIG) and Adagen are subject to Precertification. If Precertification requirements apply Aetna considers these medications to be medically necessary for those members who meet the following precertification criteria: (see also Appendix A)

Aldi weekly ad dickson tn.

Precertification of sutimlimab-jome (Enjaymo) is required of all Aetna participating providers and members in applicable plan designs. For precertification of sutimlimab-jome (Enjaymo), call (866) 752-7021, or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty Pharmacy Precertification .Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Bravelle, Cetrotide, chorionic gonadotropin, Follistim AQ, Ganirelix AC, Gonal-F/Gonal-F RFF, Menopur, novarel, Ovidrel, and pregnyl, are subject to precertification.If precertification requirements apply, Aetna considers these medications to be medically necessary for those members who ...Precertification of inclisiran (Leqvio) is required of all Aetna participating providers and members in applicable plan designs. For precertification of inclisiran (Leqvio), call (866) 752-7021 or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty Pharmacy Precertification.1 // // // Soliris (eculizumab) Injectable Medication precertification request Aetna precertification Notification503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 Page 1 of 3(All fields must be completed and legible for precertification Review.)

503 Sunport Lane, Orlando, FL 32809. Phone: 1-866-503-0857 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax:Phone: 1-866-752-7021 FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Please indicate: Start of treatment: Start date Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION .1-866-503-0857. For other lines of business: Please use other form. Note: Granix, Leukine, Neupogen, Nivestym, and Releuko are non-preferred. Zarxio is preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentPhone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 For other lines of business: Please use other form. Note: Fylnetra, Nyvepria, Rolvedon, Stimufend, Udenyca and Udenyca Onbody are non-preferred. Fulphila and Neulasta/Neulasta Onpro are preferred. (All fields must be completed and legible for precertification review.) Patient First Name503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued) – Required clinical information must be completed in its entirety for all precertification requests.1-866-503-0857 . For other lines of business: Please use other form. Note: Abraxane is non-preferred. The preferred products are docetaxel or paclitaxel. Docetaxel and paclitaxel do not require precertification. (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / /1-866-752-7021. FAX: 1-888-267-3277. For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT ...For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lucentis and Cimerli are non- preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require ...Phone: 1-866-503-0857 (TTY:711) FAX: 1-844-268-7263 . For other lines of business: Please use other form . Note: Epogen, Jesduvroq and Retacrit are non-preferred. The preferred products are Aranesp and Procrit. Page 1 of 3 (All fields must be completed and legible for precertification review.) Please indicate:MEDICARE FORM Viscosupplementation Injectable Medication Precertification Request Page 2 of 2 (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: PHONE: 1-866-503-0857 FAX: 1-844-268-7263 For other lines of business: Please use other form. Note: Durolane, Euflexxa, Gel-One, Gelsyn-3, …Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-7021 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed in its entirety for all precertification requests. Please indicate which eye the treatment is being requested for?1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy,Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...

1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...

Specialty Medication Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 Medication, Request, Specialty, Specialty medication. PRESCRIPTION D PRIOR AUTHORIZATION ...PHONE: 1-866-503-0857 . For other lines of business: Please use other form . Note: Trelstar is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatmentPhone: 1-866-752-7021 FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: Continuation of therapy, date of last treatment: Precertification Requested By: Phone: Fax:The toll-free 866 reverse lookup is a feature that allows anyone receiving a call from a toll-free number beginning with 866 to find out the name of the business calling. Reverse l...1-866-752-7021 Injectable Precertification Request FAX: 1-888-267-3277 Page 2 of 4 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 – Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)Page 2 of 2. (All fields must be completed and legible for precertification review.) Patient First Name. Patient Last Name. Patient Phone. For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857. For other lines of business: please use other form. Note: Simponi Aria is preferred for MA plans and non-preferred for MAPD plans.1-866-503-0857 . or fax applicable request forms to . 1-888-267-3277, with the following exceptions: • For precertification of pharmacy-covered specialtydrugs (noted with*) when memberis enrolled in a commercial plan, call . 1-855-240-0535 . or fax applicable request forms to . 1-877-269-9916 • Providers can use the drug-specificThe following phone numbers, websites, and emails have been reported to us by the consumer. If you feel this information is incorrect, you may submit a request for removal or correction by contacting us using this form. Phone numbers. Websites. Add new info. Phone Numbers ☎. Phone Numbers ☎. 757-587-1858. 855-207-9777.

Aandp commonlit answers.

Alexis mcadams married.

1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (continued)1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /PHONE: 1-866-503-0857 . For other lines of business: Please use other form . Note: Trelstar is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatmentDrug. Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. For Oral Corticosteroid Clinical policy click here. Policy: Note: The provision of physician samples does not guarantee coverage under the provisions of the pharmacy benefit.Aetna Precertification Notification 503 Sunport Lane Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277. Please indicate: Start of treatment. Continuation of therapy.1-866-752-7021 . FAX: 1-888-267-3277 . Page 1 of 1 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax:1-866-503-0857. Or fax applicable request forms to . 1-888-267-3277. 9. Dorsal column (lumbar) neurostimulators: trial or implantation ... For the followingservices,providers call1-866-503-0857orfax applicable request forms to 1-888-267-3277,withthe following exceptions: • Forprecertificationof pharmacy -coveredspecialtydrugs(notedwith ...Drug: Cosentyx® (secukinumab) Note: Precertification review for this medication is handled by Aetna Pharmacy Management Precertification at 1-855-240-0535 or fax applicable request forms to 1-877-269-9916. Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-32771-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First NameAdvertisement Please copy/paste the following text to properly cite this HowStuffWorks.com article: Advertisement Advertisement AdvertisementIf you received this transmission in error, please notify us immediately by telephone at (866) 503-0857. GR-69377 (5-18) Title: Diabetic Testing Supplies Prior Authorization Request Form Author: CQF Subject: Accessible - Diabetic …1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / / ….

Food stamps, known technically as the Supplemental Nutrition Assistance Program, are a benefit are designed to help those who need it to purchase and eat healthy food. Food stamps ...1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION - Required clinical information must be completed in its entirety for all precertification requests.GR-69025-1 CO (10-14) Fax this form to: 1 -877 269 9916 For specialty drugs fax to: 1-888-267-32771-866-503-0857 . For other lines of business: Please use other form. Note: Tremfya is non-preferred. Preferred products vary based on (All fields must be completed and legible for precertification review.) indication. See section G below. Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentSynagis™ (palivizumab ) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Refer to Medical CPB #0318 Synagis (Palivizumab) Policy: Precertification Criteria. Under some plans, including plans that use an open or closed formulary, Synagis is subject to precertification.1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 2 of 2 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 / / Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATIONDrug: Botox® (onabotulinumtoxinA) Dysport® (abobotulinumtoxinA) Myobloc® (rimabotulinumtoxinB) Xeomin® (incobotulinumtoxinA) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857 866-503-0857, 1-866-503-0857 . For other lines of business: Please use other form . Note: Signifor LAR is non-preferred for acromegaly. The preferred products are Sandostatin LAR and Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy, Date of last ..., 1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /, Reverse phone lookup for (866) 503-0857. Find full name, address, email, and photos for owner of (866) 503-0857 with Spokeo., Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-7021 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed in its entirety for all precertification requests. Please indicate which eye the treatment is being requested for?, Aetna Precertification Notification. 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277., 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Breast implant associated anaplastic large cell lymphoma, Cutaneous anaplastic large cell lymphoma, Systemic anaplastic large cell lymphoma (ALCL), 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax:, Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests., PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lucentis and Cimerli are non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. Patient First Name, 1-866-503-0857 . For other lines of business: Please use other form . Note: Signifor LAR is non-preferred for acromegaly. The preferred products are Sandostatin LAR and Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy, Date of last ..., Phone: 1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment ., Specialty Pharmacy Clinical Policy Bulletins. Aetna Non-Medicare Prescription Drug Plan. Subject: Remicade. Drug. Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service ..., 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Revie w.) Please indicate: Start of treatment: Start date: Continuation of therapy: Precertification Requested By:, 1-866-503-0857 . For other lines of business: Please use other form. Note: Fulphila, Nyvepria and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last ..., 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ..., Note: Required Precertification: Precertification of crizanlizumab-tmca (Adakveo) is required of all Aetna participating providers and members in applicable plan designs. For precertification of crizanlizumab-tmca (Adakveo), call (866) 752-7021 or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty ..., If you are not the intended recipient, you are notified that any use, distribution or copying of the attached material is strictly prohibited and may subject you to criminal or civil penalties. If you received this transmission in error, please notify us immediately by telephone at (866) 503-0857. GR-69377 (5-18), 503 Sunport Lane, Orlando, FL 32809. Phone: 1-866-503-0857 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax:, Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatment . Precertification Requested By: Phone: Fax:, 1-866-503-0857 . For other lines of business: Please use other form. Note: Lucentis and Byooviz are non-preferred. The preferred product is bevacizumab (Avastin). Avastin (C9257), Alymsys, Mvasi, and Zirabev do not require precertification for ophthalmic use. (All fields must be completed and legible for precertification review.) Please indicate:, Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 Pulmonary Arterial Hypertension (Infusible, Inhalation, or Injectable Medication) Precertification Request For Medicare Advantage Part B: FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date ..., 1-866-503-0857 . For other lines of business: Please use other form. Note: Tremfya is non-preferred. Preferred products vary based on (All fields must be completed and legible for precertification review.) indication. See section G below. Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /, 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ..., Repository H. P. Gel Aetna Precertification Notification 503 Sunport Lane Orlando FL 32809 Phone 1-866-503-0857 FAX 1-888-267-3277 Injectable Medication Precertification Request Request form must be completed entirely for precertification request. Date / F. PRESCRIPTION To be completed for precertification request. Prescriptions will be …, For Medicare Part B plans, call (866) 503-0857, or fax (844) 268-7263. Hepatitis B Immune Globulin. Criteria for Initial Approval. Aetna considers hepatitis B immune globulin medically necessary for members who have had contact with an individual diagnosed with hepatitis B virus (HBV). Risk groups include infants born to hepatitis B surface ..., Osteoporosis Injectable Medication. Recertification Request. Aetna Recertification Notification. 503 Support Lane, Orlando, FL 32809. Phone: 1-866 -503-0857 ..., Drug: Taltz® (ixekizumab) Note: Precertification review for this medication is handled by Aetna Pharmacy Management Precertification at 1-855-240-0535 or fax applicable request forms to 1-877-269-9916. Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277., 503 Sunport Lane, Orlando, FL 32809 . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review) Please indicate: Start of treatment: Start date: / / Continuation of therapy: Date of last treatment / /, Page 2 of 2. (All fields must be completed and legible for precertification review.) Patient First Name. Patient Last Name. Patient Phone. For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857. For other lines of business: please use other form. Note: Simponi Aria is preferred for MA plans and non-preferred for MAPD plans., Acetazolamide: learn about side effects, dosage, special precautions, and more on MedlinePlus Acetazolamide is used to treat glaucoma, a condition in which increased pressure in th..., Aetna Precertification Notification 503 Sunport Lane Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277. Please indicate: Start of treatment. Continuation of therapy., 1-866-503-0857 . For other lines of business: Please use other form. Note: Ilumya is non-preferred. Preferred products may vary based on indication. See section G below. (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment, 1-844-268-7263. PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Vabysmo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use.